ODT - Odonate Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
0
0
0
0
0
Cost of Revenue
-
-
-
-
-
Gross Profit
-
-
-
-
-
Operating Expenses
Research Development
104,978
79,948
27,902
2,622
0
Selling General and Administrative
10,720
10,816
4,842
463
158
Total Operating Expenses
115,698
90,764
32,744
3,085
158
Operating Income or Loss
-115,698
-90,764
-32,744
-3,085
-158
Interest Expense
-
-
-
-
-
Total Other Income/Expenses Net
-
-
-
0
0
Income Before Tax
-112,737
-88,960
-32,744
-3,085
-158
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-112,737
-88,960
-32,744
-3,085
-158
Net Income
-112,737
-88,960
-32,744
-3,085
-158
Net Income available to common shareholders
-112,737
-88,960
-32,744
-3,085
-158
Reported EPS
Basic
-
-3.64
-2.31
-0.11
-0.01
Diluted
-
-3.64
-2.31
-0.11
-0.01
Weighted average shares outstanding
Basic
-
24,462
14,169
26,890
26,890
Diluted
-
24,462
14,169
26,890
26,890
EBITDA
-
-90,414
-32,724
-3,085
-158